Mirae Asset Global Investments Co., Ltd. Arvinas, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,301 shares of ARVN stock, worth $16,774. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,301
Previous 2,290
0.48%
Holding current value
$16,774
Previous $43,000
62.79%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$61 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$45.6 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$28.3 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$27.9 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$24.3 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $388M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...